Light flicker therapy aims to sharpen aging brains
NCT ID NCT07395609
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether three months of flicker stimulation (using near-infrared light or visual occlusion glasses) can improve thinking, movement, and mood in healthy older adults and those with subjective cognitive decline. Sixty participants aged 65-89 will be assigned to different stimulation groups. Researchers will measure changes in cognition, grip strength, walking speed, balance, and brain structure using MRI and blood tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Flicker stimulation (near-infrared light and visual occlusion glasses)
What this could lead to
If it works, this could point toward a non-invasive way to slow age-related brain changes and improve daily function in older adults.
What could go wrong
This is an early-stage study with only 60 participants, so results may not apply widely. The intervention is experimental and may not produce meaningful benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida
Gainesville, Florida, 32611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••